Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01638455 · ClinicalTrials.gov registry record · NA
Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 2,776
- Enrollment target
NCT01638455 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 2,776 participants.
The verdict
NCT01638455, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,776 participants
- Enrollment target
Study Summary
Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.
Interventions
- DEVICE Noninvasive device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,776 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-09-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01638455
The ClinicalTrials.gov registry entry for NCT01638455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,776 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Noninvasive device is the first listed.
NCT01638455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01638455 about?
NCT01638455 is a clinical study titled "Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples". Characterize Masimo noninvasive technology in spot check reading on subjects and make comparison to invasive blood sampling tested on reference analyzers.
What is the current status of trial NCT01638455?
This trial is currently completed. It is a NA study. The enrollment target is 2,776 participants. The study started on 2012-06. Estimated completion is 2016-09-07.
What interventions are being tested in trial NCT01638455?
The interventions under investigation include: Noninvasive device (DEVICE).
Who is sponsoring clinical trial NCT01638455?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.